Your browser doesn't support javascript.
loading
Non-small cell lung cancer clinical trials requiring biopsies with biomarker-specific results for enrollment provide unique challenges.
Spiegel, Marshall L; Goldman, Jonathan W; Wolf, Brian R; Nameth, Danielle J; Grogan, Tristan R; Lisberg, Aaron E; Wong, Deborah J L; Ledezma, Blanca A; Mendenhall, Melody A; Genshaft, Scott J; Gutierrez, Antonio J; Abtin, Fereidoun; Wallace, W Dean; Adame, Carlos R; McKenzie, Jordan R; Abarca, Phillip A; Li, Alice J; Strunck, Jennifer L; Famenini, Sina; Carroll, James M; Tucker, D Andrew; Sauer, Lauren M; Moghadam, Nima M; Elashoff, David A; Abaya, Christina D; Brennan, Meghan B; Garon, Edward B.
Affiliation
  • Spiegel ML; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Goldman JW; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Wolf BR; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Nameth DJ; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Grogan TR; Department of Medicine, Statistics Core, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Lisberg AE; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Wong DJL; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Ledezma BA; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Mendenhall MA; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Genshaft SJ; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Gutierrez AJ; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Abtin F; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Wallace WD; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Adame CR; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • McKenzie JR; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Abarca PA; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Li AJ; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Strunck JL; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Famenini S; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Carroll JM; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Tucker DA; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Sauer LM; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Moghadam NM; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Elashoff DA; Department of Medicine, Statistics Core, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Abaya CD; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Brennan MB; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
  • Garon EB; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California.
Cancer ; 123(24): 4800-4807, 2017 Dec 15.
Article de En | MEDLINE | ID: mdl-29125624
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Marqueurs biologiques tumoraux / Carcinome pulmonaire non à petites cellules / Sélection de patients / Tumeurs du poumon Type d'étude: Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: Cancer Année: 2017 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Marqueurs biologiques tumoraux / Carcinome pulmonaire non à petites cellules / Sélection de patients / Tumeurs du poumon Type d'étude: Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: Cancer Année: 2017 Type de document: Article Pays de publication: États-Unis d'Amérique